Mode
Text Size
Log in / Sign up

Pressure-controlled volume-guaranteed ventilation improved diaphragmatic function and reduced weakness in diabetic patients undergoing laparoscopic colorectal surgery.

Pressure-controlled volume-guaranteed ventilation improved diaphragmatic function and reduced weakne…
Photo by Stephen Andrews / Unsplash
Key Takeaway
Consider that PCV-VG improved diaphragmatic function but did not reduce PPCs in diabetic patients undergoing laparoscopic colorectal surgery.

This randomized controlled trial evaluated the effects of pressure-controlled volume-guaranteed ventilation (PCV-VG) versus volume-controlled ventilation (VCV) in a cohort of 80 patients diagnosed with Type 2 diabetes undergoing elective laparoscopic colorectal surgery. The primary outcomes focused on diaphragmatic function, assessed via diaphragm thickening fraction (DTF) and diaphragm excursion (DE), while secondary outcomes included intraoperative mechanical power, postoperative pulmonary complications (PPCs), and other complications within the first two days post-surgery.

Results indicated that the PCV-VG group demonstrated significantly lower intraoperative mechanical power compared to the VCV group, with a p-value of 0.002. Furthermore, diaphragm excursion and thickening fraction were significantly improved in the PCV-VG group during the initial two postoperative days. The incidence of postoperative diaphragmatic weakness was also less frequent in the PCV-VG group (p = 0.019). However, no statistically significant difference was found in the incidence of PPCs between the two ventilation strategies (p = 0.155).

Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported in the study. The authors note that although improvements in diaphragmatic function were observed, these physiological benefits did not translate into a reduction in the clinical incidence of PPCs. This suggests that while PCV-VG may optimize diaphragm mechanics, its broader clinical utility in preventing pulmonary complications in this specific population remains uncertain based on these findings.

Study Details

Study typeRct
EvidenceLevel 2
PublishedDec 2026
View Original Abstract ↓
BACKGROUND: Diabetic patients are prone to induce diaphragmatic weakness, which can lead to postoperative pulmonary complications (PPCs). The optimal mechanical ventilation mode may potentially improve postoperative diaphragmatic function. This study evaluates the effects of two ventilation modes under driving pressure-guided ventilation strategy on diaphragmatic function, as assessed by diaphragm thickening fraction (DTF) and diaphragm excursion (DE), in diabetic patients following laparoscopic colorectal surgery. METHODS: Eighty patients diagnosed with Type II diabetes scheduled for elective laparoscopic colorectal surgery, were randomly allocated to either the pressure-controlled volume-guaranteed ventilation (PCV-VG) group (Group P) or the volume-controlled ventilation (VCV) group (Group V) during surgery. The primary outcome was diaphragmatic function assessed during both tidal breathing and maximal inspiratory effort after surgery. Secondary outcomes included intraoperative mechanical power, PPCs, and other complications. RESULTS: A total of eighty patients were included in the final analysis. The averaged area under the curve (AUC) for mechanical power during ventilation was significantly lower in Group P than in Group V ( = 0.002). PCV-VG significantly improved both DE and DTF within the first two days post-surgery (AUC:  = 0.088, AUC:  = 0.004, AUC:  = 0.029, AUC:  = 0.017). Postoperative diaphragmatic weakness was less frequent in Group P than in Group V ( = 0.019). However, there was no difference in the incidence of PPCs between the two groups ( = 0.155). CONCLUSION: PCV-VG mode can reduce intraoperative mechanical power, better preserve postoperative diaphragmatic function. However, these improvements did not translate into clinical benefits, as evidenced by the lack of reduction in the incidence of PPCs.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.